This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Shanghai Hutchison Pharmaceuticals Limited. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Chenguo Feng: Innovator in Glycoside Compounds
Introduction
Chenguo Feng is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of glycoside compounds. His work focuses on innovative methods that can enhance medical treatments.
Latest Patents
Chenguo Feng holds a patent for a glycoside compound and its preparation method, as well as its composition, application, and intermediate. The patent describes a glycoside compound represented by Formula III. This invention features a simple preparation method and has been shown to significantly increase the expression of VEGF-A mRNA. It is effective in promoting angiogenesis, which is crucial for developing drugs aimed at treating conditions such as cerebral infarction, myocardial infarction, and ischemic microcirculatory disturbances in lower limbs.
Career Highlights
Chenguo Feng is currently associated with Shanghai Hutchison Pharmaceuticals Limited. His work at this company has allowed him to focus on innovative pharmaceutical solutions that address critical health issues. His research and inventions have the potential to impact the medical field positively.
Collaborations
Chenguo Feng collaborates with talented individuals such as Jiange Zhang and Guoqiang Lin. Their combined expertise contributes to the advancement of their projects and the development of new pharmaceutical innovations.
Conclusion
Chenguo Feng is a prominent inventor whose work in glycoside compounds holds promise for significant advancements in medical treatments. His contributions are vital for the future of drug development aimed at serious health conditions.